Company Overview of QBiotics Group Limited
QBiotics Limited researches and develops pharmaceutical products to treat various health problems for humans and companion animals (dogs, cats, and horses). The company focuses on solid tumour cancer and wound healing. Its products include EBC-46 for human anti-cancer treatment for skin, head and neck, breast, prostate, and colorectal cancers; and WH1, which is used as a wound healing agent. The company was founded in 2004 and is headquartered in Taringa, Australia.
165 Moggill Road
Taringa, QLD 4068
Founded in 2004
61 7 3870 8933
61 7 4089 7778
Key Executives for QBiotics Group Limited
Similar Private Companies By Industry
|AbRegen Pty Ltd.||Asia|
|Advanced Wound Care Pty Ltd.||Asia|
|Agriliance Pty Ltd.||Asia|
|AION Diagnostics Limited||Asia|
|Aquaceutics Pty Ltd||Asia|
Recent Private Companies Transactions
August 17, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact QBiotics Group Limited, please visit www.qbiotics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.